IASO Biotherapeutics
Mr. Zhang joined IASO Biotherapeutics in September 2022, and is currently the company’s Chief Commercial Officer.
Mr. Zhang graduated from Shanghai Medical University with a bachelor's degree in pharmacology, and later obtained an MBA degree from Fudan University. He has been engaged in marketing management in the field of cancer for more than 20 years since 1998, and has profound understanding of pharmaceutical marketing and rich experience in marketing innovative cancer drugs.
He has successively served as the National Sales Director of the Tumor Business Department of Pfizer Inc., the Business Director of the Northern China Tumor Business Department of Merck Serono, the Business Director of the Special Treatment of Bayer Healthcare, and the Deputy Chief Commercial Officer of Fosun Kate Biotechnology.
This person is not in any offices
IASO Biotherapeutics
IASO Biotherapeutics is a biopharmaceutical company focused on the development of cell therapies in the field of oncology.